NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 388 filers reported holding NEKTAR THERAPEUTICS in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,954 | -69.5% | 14,161 | -2.0% | 0.00% | -100.0% |
| Q4 2022 | $32,668 | -92.1% | 14,455 | +112.6% | 0.00% | -97.4% |
| Q3 2018 | $414,000 | +24.3% | 6,798 | -0.3% | 0.04% | +11.8% |
| Q2 2018 | $333,000 | -56.0% | 6,818 | -4.3% | 0.03% | -58.5% |
| Q1 2018 | $757,000 | +83.7% | 7,128 | +3.3% | 0.08% | +82.2% |
| Q4 2017 | $412,000 | – | 6,898 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Strong Tower Advisory Services | 404,972 | $6,913,000 | 4.02% |
| GREAT POINT PARTNERS LLC | 504,691 | $9,064,000 | 2.11% |
| Camber Capital Management LP | 3,750,000 | $67,350,000 | 2.07% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,901,000 | 1.50% |
| Rhenman & Partners Asset Management AB | 950,000 | $17,062,000 | 1.20% |
| MAVERICK CAPITAL LTD | 5,838,426 | $104,858,000 | 1.06% |
| Birchview Capital, LP | 72,000 | $1,293,000 | 0.88% |
| Bellevue Group AG | 4,594,656 | $82,519,000 | 0.84% |
| CM Management, LLC | 50,000 | $898,000 | 0.67% |
| Duquesne Family Office | 1,000,000 | $17,960,000 | 0.58% |